Fifty proteins with one job description
The complement system is described as a set of roughly fifty proteins circulating in blood serum, and the material is careful to frame its purpose in relational terms: complement does not act as an independent line of defence so much as amplify what antibodies and phagocytic cells are already doing. It can mark pathogens for engulfment, trigger inflammation, and, in its final stage, kill target cells directly by disrupting their membrane. Although classified as part of innate immunity, meaning it does not need to learn a pathogen the way antibodies do, the system is also activated by antibodies themselves, making it one of the clearer points of overlap between the innate and adaptive branches of immunity. This dual identity, an innate system routinely switched on by an adaptive one, is presented as central to understanding why complement matters beyond its own cascade.
Three roads to the same cascade
Three separate pathways can start the complement cascade, and each responds to a different kind of signal. The classical pathway begins when a specific complement protein binds to antibodies already attached to a pathogen, meaning it depends on the adaptive immune system having already produced a response. The lectin pathway works similarly but is triggered instead by a protein that recognises sugar patterns common on microbial surfaces, requiring no antibody involvement at all. The alternative pathway is described as continuously ticking over at a low level through spontaneous activation of one central complement protein, ready to accelerate immediately if that protein happens to land on a pathogen’s surface, and it is credited with driving the majority of the cascade’s later activity regardless of which pathway started it.
A hole punched straight through the membrane
All three pathways converge on the same downstream events, culminating in the assembly of what is called the membrane attack complex. Several complement proteins combine to form a physical channel through the membrane of a target cell, and this channel is not a chemical trigger but an actual structural breach, causing the cell to rupture through simple osmotic imbalance as water and ions move freely across the compromised membrane. Earlier in the cascade, one particular fragment acts as an opsonin, coating a pathogen’s surface and making it far easier for phagocytic cells to recognise and engulf, while two other fragments released during the cascade act as signalling molecules that trigger inflammation directly, recruiting additional immune cells to the site and increasing local blood vessel permeability.
A name born from a 19th century argument
The discovery history given here runs across roughly a decade at the end of the nineteenth century. George Nuttall observed in 1888 that fresh sheep serum could kill anthrax bacteria, an effect destroyed by heating the serum. Hans Buchner named this heat-sensitive killing factor alexin a few years later. Jules Bordet, working at the Pasteur Institute, then showed that heat-inactivated serum could still confer protection in guinea pigs exposed to cholera, concluding that two separate components were involved, one heat-stable and one heat-sensitive. Paul Ehrlich renamed the heat-sensitive component complement in 1899, on the reasoning that it completed or complemented the antimicrobial capability already provided by the heat-stable, antibody-related component, a naming choice that has stuck for well over a century.
The brakes matter as much as the cascade
Because the complement cascade ends in destroying a cell’s membrane, it needs tight control to avoid damaging the body’s own healthy tissue, and the material treats this regulatory layer as just as important as the activating one. Proteins such as factor H and factor I inactivate a key complement fragment before it can build a destructive complex, while other regulatory proteins present on healthy cell surfaces specifically block the final membrane attack steps, effectively marking self-tissue as off-limits. When these regulatory proteins fail through mutation, the consequences are specific and severe: alterations affecting factor H are linked to atypical haemolytic uraemic syndrome and to age-related macular degeneration, while deficiencies in the terminal pathway itself leave people vulnerable to recurrent meningococcal infection, since the membrane attack complex is a primary defence against that particular bacterium.
A defence system with an unrelated second job
Beyond infection and disease, the material closes on a finding that sits outside the traditional immune-defence framing entirely: complement proteins have been shown to participate in pruning synaptic connections during brain development, tagging weaker or unnecessary synapses for removal in a process that shapes neural circuitry rather than fighting a pathogen. This is worth an hour precisely because it resists the instinct to treat complement as a single-purpose defence system; the same molecular toolkit that punches holes in bacterial membranes also appears to help sculpt the developing brain. The discovery history gives the biochemistry a satisfying, well-documented backbone, and the disease section grounds the abstract cascade in specific, named conditions rather than vague talk of immune dysfunction.